Market Overview

Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue

Related HSP
Hospira Granted Temporary Restraining Order Against FDA, Shares Pop Higher
BioScrip Posts Wider-than-Expected Q2 Loss on Poor Margins
Related VRX
Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.
Benzinga's M&A Chatter for Monday September 22, 2014
Allergan Rebuffs Valeant's Tender Offer (Fox Business)

Below are the top drug delivery stocks on the NYSE in terms of revenue.

The trailing-twelve-month revenue at Hospira (NYSE: HSP) is $4.02 billion. Hospira had $655.90 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Valeant Pharmaceuticals International (NYSE: VRX) is $2.75 billion. Valeant Pharmaceuticals' operating margin for the same period is 23.99%.

The trailing-twelve-month revenue at Elan Corporation plc (NYSE: ELN) is $1.29 billion. Elan's ROE for the same period is 102.84%.

The trailing-twelve-month revenue at K-V Pharmaceutical Company (NYSE: KV-A) is $23.20 million. K-V Pharmaceutical had $50.70 million in total cash for the latest quarter.

Posted-In: Drug Delivery Industry Highest Revenue NYSETrading Ideas

 

Related Articles (ELN + HSP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters